🔎 Trials Near Me

Akèy › Obèsite › Lwizyàn › Baton Rouge

Etid klinik pou Obèsite nan Baton Rouge, LA

16 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Baton Rouge (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Ap rekriteFaz 3
  • Pennington Biomed Res Ctr, Baton Rouge
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • Southern Clin Research, Zachary · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

Pennington Generation Cohort

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Pennington Biomedical Research Center, Baton Rouge
Tout laj · Tout sèks · Mizajou Sep 17, 2026 · NCT06849206

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, Baton Rouge
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Baton Rouge
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Our Lady of the Lake Medical Center, Baton Rouge
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Velocity Clinical Research - Baton Rouge, Baton Rouge
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3
  • Pennington Biomedical Research Center, Baton Rouge
Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

Collaborative Multi-level Obesity Intervention Engaging Communities Trial

Ap rekrite
  • CareSouth Medical and Dental - Baton Rouge Clinic, Baton Rouge
  • CareSouth Medical and Dental - Plaquemine Clinic, Plaquemine · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 11, 2026 · NCT06835686

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, Baton Rouge
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

Low Oxygen Exposure and Weight Status

Ap rekriteVolontè an sante akeyi
  • Pennington Biomedical Research Center, Baton Rouge
Laj 22 a 65 · Tout sèks · Mizajou Jul 16, 2026 · NCT05289310

Body Composition Outcomes in MS Patients

Ap rekriteEtid obsèvasyon
  • Pennington Biomedical Resarch Center, Baton Rouge
  • Pennington Biomedical Research Center, Baton Rouge
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT07530718

Experimental Approach to Test Predictions of Body Weight Regulation Models

Ap rekriteVolontè an sante akeyi
  • Pennington Biomedical Research Center, Baton Rouge
Laj 18 a 40 · Tout sèks · Mizajou May 29, 2026 · NCT06309576

Iron Absorption in The Low Oxygen Exposure and Weight Status (LOWS) Study

Ap rekrite
  • Pennington Biomedical Research Center, Baton Rouge
Laj 22 a 65 · Tout sèks · Mizajou Apr 21, 2026 · NCT07542873

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

Ap rekriteVolontè an sante akeyi
  • Pennington Biomedical Research Center, Baton Rouge
Laj 18 a 42 · Tout sèks · Mizajou Apr 8, 2026 · NCT04583514

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

Ap rekriteVolontè an sante akeyi
  • Pennington Biomedical Research Center, Baton Rouge
Laj 18 a 45 · Tout sèks · Mizajou Mar 27, 2026 · NCT06602141

Etid Obèsite nan lòt vil

Lòt etid nan Baton Rouge

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.